Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • VTI vs GSK✓SelectedUSD · GSKVTI vs GSK performance historyLatest closeAs of-1.84%11/16
Stock and ETF performance explorer

VTI vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+278.1%
GSK return
+108.8%
Excess return
+169.3%
Maximum drawdown
-35.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.8%-0.1%-1.8%-1.8%
7D-1.8%-1.3%-0.5%-1.4%
30D-2.6%+2.7%-5.3%-3.5%
3M-4.9%+2.7%-7.6%-5.9%
6M+1.0%+3.3%-2.4%-0.7%
YTD+9.6%+6.5%+3.1%+6.1%
1Y+11.7%+10.7%+1.0%+6.7%
3Y+70.1%+64.4%+5.7%+36.3%
5Y+60.8%+46.7%+14.1%+32.6%
All+278.1%+108.8%+169.3%+168.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling